The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination (Q42726956)
Jump to navigation
Jump to search
scientific article published on 6 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination |
scientific article published on 6 September 2011 |
Statements
1 reference
The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination (English)
1 reference
1 reference
Helen Zhao
1 reference
Kaisa R Luoto
1 reference
Alice X Meng
1 reference
6 September 2011
1 reference
1 reference
101
1 reference
1
1 reference
59-65
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference